IGF1 and urinary bladder carcinoma: Moreover, a moderately large sample size allowed us to make reasonably precise estimates of the relationship between circulating IGF‐I concentrations and bladder cancer, while information on tumour subtypes enabled us to explore possible heterogeneity in bladder cancer risk by tumour aggressiveness.